Estimated number of persons receiving coadministered drugs used in preventive chemotherapy for NTDs, by drug combination, as well as source of these estimates.</p
Green lines represent WHO-recommended combinations. Red lines represent non-WHO-recommended combinat...
* “Number” indicates the number of patients who used the drug concerned concomitantly within 7 days ...
The figure shows the proportion of patients taking one ore more concomitant medications in this real...
<p>Drugs Utilized for Preventive Chemotherapy for Different Neglected Diseases Transmitted in WPR Co...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
<p>Descriptive statistics of the adjuvant chemotherapy and molecular targeted agents employed in eac...
Distribution of medications used to the treatment of T2DM patients with comorbidity.</p
<p><b>Additional Note:</b> For Targeted NCD medicines which addressed more than one Targeted NCD, fr...
<p>M: melphalan; T: topotecan; C: carboplatin.</p><p>The number of patients treated per cycle with t...
<p>Number of patients with potentially contraindicated drug-drug interactions Number of patients wit...
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis ...
<p>The number of drugs plotted against the number of cancers they can treat in the benchmark dataset...
<p>People Who Inject Drugs Prevalence Rates per 10,000 population: PWID Total and Subpopulations, 19...
The proportion of participants with the respective number of dispensed medications among patients wi...
<p>Cumulative Number of Male and Female PWIDs Initiating Medication Assisted Treatment.</p
Green lines represent WHO-recommended combinations. Red lines represent non-WHO-recommended combinat...
* “Number” indicates the number of patients who used the drug concerned concomitantly within 7 days ...
The figure shows the proportion of patients taking one ore more concomitant medications in this real...
<p>Drugs Utilized for Preventive Chemotherapy for Different Neglected Diseases Transmitted in WPR Co...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
<p>Descriptive statistics of the adjuvant chemotherapy and molecular targeted agents employed in eac...
Distribution of medications used to the treatment of T2DM patients with comorbidity.</p
<p><b>Additional Note:</b> For Targeted NCD medicines which addressed more than one Targeted NCD, fr...
<p>M: melphalan; T: topotecan; C: carboplatin.</p><p>The number of patients treated per cycle with t...
<p>Number of patients with potentially contraindicated drug-drug interactions Number of patients wit...
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis ...
<p>The number of drugs plotted against the number of cancers they can treat in the benchmark dataset...
<p>People Who Inject Drugs Prevalence Rates per 10,000 population: PWID Total and Subpopulations, 19...
The proportion of participants with the respective number of dispensed medications among patients wi...
<p>Cumulative Number of Male and Female PWIDs Initiating Medication Assisted Treatment.</p
Green lines represent WHO-recommended combinations. Red lines represent non-WHO-recommended combinat...
* “Number” indicates the number of patients who used the drug concerned concomitantly within 7 days ...
The figure shows the proportion of patients taking one ore more concomitant medications in this real...